Conservative Management Following Complete Clinical Response to Neoadjuvant Chemotherapy of Muscle Invasive Bladder Cancer: Contemporary Outcomes of a Multi-Institutional Cohort Study | Zendy

P Mazza | Zendy; George W. Moran | Zendy; Gen Li | Zendy; Dennis Robins | Zendy; Justin T. Matulay | Zendy; Harry W. Herr | Zendy; G. Joel DeCastro | Zendy; James M. McKiernan | Zendy; Christopher B. Anderson | Zendy

Open Access

Conservative Management Following Complete Clinical Response to Neoadjuvant Chemotherapy of Muscle Invasive Bladder Cancer: Contemporary Outcomes of a Multi-Institutional Cohort Study

Author(s) -

P Mazza,

George W. Moran,

Gen Li,

Dennis Robins,

Justin T. Matulay,

Harry W. Herr,

G. Joel DeCastro,

James M. McKiernan,

Christopher B. Anderson

Publication year - 2018

Publication title -

the journal of urology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.402

H-Index - 256

eISSN - 1527-3792

pISSN - 0022-5347

DOI - 10.1016/j.juro.2018.05.078

Subject(s) - medicine , cystectomy , bladder cancer , chemotherapy , cohort , neoadjuvant therapy , cancer , surgery , urology , oncology , breast cancer

We report the outcomes in patients with muscle invasive bladder cancer from 2 institutions who experienced a clinically complete response to neoadjuvant platinum based chemotherapy and elected active surveillance. It was unknown whether conservative treatment could be safely implemented in these patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research